Ren-Xiong Chen1,2, Zhou-Qiao Wu2, Zi-Yu Li2, Hong-Zhi Wang1, Jia-Fu Ji2. 1. ICU, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China. 2. Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
Abstract
BACKGROUND: The purpose of this study was to evaluate the health economics of patients with sepsis after gastrointestinal tumor operation in ICU. METHODS: This case-control study used 1:1 propensity-score (PS) matched method and patients were matched according to tumor type, age and gender. The study group was composed of 181 patients with sepsis after operation of gastrointestinal tumor in ICU, while the control group was composed of 181 patients without sepsis after operation of gastrointestinal tumor. The medical expenses and length of stay in the hospital of these patients were analyzed. RESULTS: The median of the total hospitalization cost for the study group was $26,038, which was 1.7 times of the control group (P<0.001). The costs of drugs, laboratory test, examination, treatment, operation, anesthesia, materials, ward and other costs in the study group were higher than those in the control group (P<0.001). The median length of stay in the hospital in the study group was 26 days, which were 12 days longer than that of the control group (P<0.001). However, there was no significant difference in daily average cost between the two groups (P=0.103). CONCLUSIONS: In ICU, patients with sepsis after operation of gastrointestinal tumor increased the cost of hospitalization and prolonged the length of stay in the hospital than those without sepsis. 2020 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: The purpose of this study was to evaluate the health economics of patients with sepsis after gastrointestinal tumor operation in ICU. METHODS: This case-control study used 1:1 propensity-score (PS) matched method and patients were matched according to tumor type, age and gender. The study group was composed of 181 patients with sepsis after operation of gastrointestinal tumor in ICU, while the control group was composed of 181 patients without sepsis after operation of gastrointestinal tumor. The medical expenses and length of stay in the hospital of these patients were analyzed. RESULTS: The median of the total hospitalization cost for the study group was $26,038, which was 1.7 times of the control group (P<0.001). The costs of drugs, laboratory test, examination, treatment, operation, anesthesia, materials, ward and other costs in the study group were higher than those in the control group (P<0.001). The median length of stay in the hospital in the study group was 26 days, which were 12 days longer than that of the control group (P<0.001). However, there was no significant difference in daily average cost between the two groups (P=0.103). CONCLUSIONS: In ICU, patients with sepsis after operation of gastrointestinal tumor increased the cost of hospitalization and prolonged the length of stay in the hospital than those without sepsis. 2020 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Health economic evaluation; gastrointestinal tumor; sepsis
Authors: Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus Journal: JAMA Date: 2016-02-23 Impact factor: 56.272
Authors: Konrad Reinhart; Ron Daniels; Niranjan Kissoon; Flavia R Machado; Raymond D Schachter; Simon Finfer Journal: N Engl J Med Date: 2017-06-28 Impact factor: 91.245
Authors: Kathryn M Rowan; Derek C Angus; Michael Bailey; Amber E Barnato; Rinaldo Bellomo; Ruth R Canter; Timothy J Coats; Anthony Delaney; Elizabeth Gimbel; Richard D Grieve; David A Harrison; Alisa M Higgins; Belinda Howe; David T Huang; John A Kellum; Paul R Mouncey; Edvin Music; Sandra L Peake; Francis Pike; Michael C Reade; M Zia Sadique; Mervyn Singer; Donald M Yealy Journal: N Engl J Med Date: 2017-03-21 Impact factor: 91.245
Authors: M Elizabeth Wilcox; Kelsey Vaughan; Christopher A K Y Chong; Peter J Neumann; Chaim M Bell Journal: Crit Care Med Date: 2019-08 Impact factor: 7.598
Authors: Michelle M A Kip; Jos A van Oers; Arezoo Shajiei; Albertus Beishuizen; A M Sofie Berghuis; Armand R Girbes; Evelien de Jong; Dylan W de Lange; Maarten W N Nijsten; Maarten J IJzerman; Hendrik Koffijberg; Ron Kusters Journal: Crit Care Date: 2018-11-13 Impact factor: 9.097